Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study.
Yamaguchi K, Masuda T, Fujitaka K, Miwata K, Sakamoto S, Horimasu Y, Hamai K, Miyamoto S, Nakashima T, Okamoto Y, Iwamoto H, Ishikawa N, Miyata Y, Okada M, Hamada H, Hattori N. Yamaguchi K, et al. Among authors: okamoto y. In Vivo. 2018 Sep-Oct;32(5):1155-1160. doi: 10.21873/invivo.11358. In Vivo. 2018. PMID: 30150438 Free PMC article. Clinical Trial.
[Informed consent for esophageal cancer].
Okamoto Y, Narahara H. Okamoto Y, et al. Nihon Rinsho. 2011 Aug;69 Suppl 6:471-4. Nihon Rinsho. 2011. PMID: 22471062 Japanese. No abstract available.
A higher CD34 + cell dose correlates with better event-free survival after KIR-ligand mismatched cord blood transplantation for childhood acute myeloid leukemia.
Ishida H, Kawahara Y, Tomizawa D, Okamoto Y, Hama A, Cho Y, Koh K, Koga Y, Yoshida N, Sato M, Terui K, Miyagawa N, Watanabe A, Takita J, Kobayashi R, Yamamoto M, Watanabe K, Okada K, Kato K, Matsumoto K, Hino M, Tabuchi K, Sakaguchi H. Ishida H, et al. Among authors: okamoto y. J Hematol Oncol. 2024 Apr 29;17(1):24. doi: 10.1186/s13045-024-01548-3. J Hematol Oncol. 2024. PMID: 38679709 Free PMC article.
3,839 results